Thomas Reinert

6.5k total citations
38 papers, 2.4k citations indexed

About

Thomas Reinert is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Reinert has authored 38 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 19 papers in Oncology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Reinert's work include Cancer Genomics and Diagnostics (19 papers), Genetic factors in colorectal cancer (13 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Thomas Reinert is often cited by papers focused on Cancer Genomics and Diagnostics (19 papers), Genetic factors in colorectal cancer (13 papers) and Bladder and Urothelial Cancer Treatments (10 papers). Thomas Reinert collaborates with scholars based in Denmark, United States and Spain. Thomas Reinert's co-authors include Torben F. Ørntoft, Lars Dyrskjøt, Claus L. Andersen, Michael Borre, Søren Laurberg, Iver Nordentoft, Søren Vang, Carsten Wiuf, Frank Viborg Mortensen and Philippe Lamy and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Thomas Reinert

36 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Reinert Denmark 20 1.4k 1.1k 800 549 540 38 2.4k
Catherine Butori France 24 659 0.5× 503 0.5× 1.3k 1.6× 250 0.5× 786 1.5× 73 2.3k
Gary L. Bratthauer United States 29 698 0.5× 917 0.9× 788 1.0× 493 0.9× 509 0.9× 64 2.8k
Ie Ming Shih United States 16 566 0.4× 713 0.7× 517 0.6× 242 0.4× 273 0.5× 19 2.2k
Chiara Casadio Italy 23 546 0.4× 342 0.3× 616 0.8× 331 0.6× 400 0.7× 77 1.8k
Francesca Micci Norway 26 390 0.3× 1.0k 1.0× 417 0.5× 228 0.4× 871 1.6× 117 2.5k
Kung‐Chao Chang Taiwan 26 368 0.3× 615 0.6× 727 0.9× 285 0.5× 150 0.3× 102 2.0k
Margaret Brandwein‐Gensler United States 31 646 0.5× 833 0.8× 1.3k 1.6× 1.8k 3.2× 428 0.8× 59 3.6k
Kolja Freier Germany 30 381 0.3× 894 0.8× 903 1.1× 835 1.5× 440 0.8× 99 2.6k
Amit Roshan United Kingdom 10 557 0.4× 765 0.7× 474 0.6× 209 0.4× 116 0.2× 24 1.7k
H. Ewout Schaafsma Netherlands 20 286 0.2× 1.3k 1.2× 483 0.6× 517 0.9× 707 1.3× 40 2.4k

Countries citing papers authored by Thomas Reinert

Since Specialization
Citations

This map shows the geographic impact of Thomas Reinert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Reinert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Reinert more than expected).

Fields of papers citing papers by Thomas Reinert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Reinert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Reinert. The network helps show where Thomas Reinert may publish in the future.

Co-authorship network of co-authors of Thomas Reinert

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Reinert. A scholar is included among the top collaborators of Thomas Reinert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Reinert. Thomas Reinert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alves, Carla L., Sidse Ehmsen, Thomas Reinert, et al.. (2024). Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4 /6 inhibitor in advanced breast cancer. International Journal of Cancer. 155(12). 2211–2222. 6 indexed citations
2.
Henriksen, Tenna Vesterman, et al.. (2024). Exploring the biology of ctDNA release in colorectal cancer. European Journal of Cancer. 207. 114186–114186. 13 indexed citations
3.
Henriksen, Tenna Vesterman, Christina Demuth, Amanda Frydendahl, et al.. (2023). Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohort. Annals of Oncology. 35(2). 229–239. 42 indexed citations
4.
Øgaard, Nadia, Thomas Reinert, Tenna Vesterman Henriksen, et al.. (2022). Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: A prospective cohort study. European Journal of Cancer. 163. 163–176. 48 indexed citations
5.
Henriksen, Tenna Vesterman, Thomas Reinert, Mads H. Rasmussen, et al.. (2022). Comparing single‐target and multitarget approaches for postoperative circulating tumour DNA detection in stage II–III colorectal cancer patients. Molecular Oncology. 16(20). 3654–3665. 11 indexed citations
6.
7.
Henriksen, Tenna Vesterman, N. Tarazona, Thomas Reinert, et al.. (2020). 420P Minimal residual disease detection and tracking tumour evolution using ctDNA in stage I-III colorectal cancer patients. Annals of Oncology. 31. S419–S420. 2 indexed citations
8.
Schøler, Lone V., Thomas Reinert, Mai‐Britt W. Ørntoft, et al.. (2017). Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer. Clinical Cancer Research. 23(18). 5437–5445. 230 indexed citations
9.
Birkenkamp‐Demtröder, Karin, Iver Nordentoft, Emil Christensen, et al.. (2016). Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer. European Urology. 70(1). 75–82. 168 indexed citations
10.
Reinert, Thomas, Lone V. Schøler, Rune Thomsen, et al.. (2015). Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. Gut. 65(4). 625–634. 351 indexed citations
11.
Fristrup, Niels, Karin Birkenkamp‐Demtröder, Thomas Reinert, et al.. (2012). Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer. American Journal Of Pathology. 182(2). 339–349. 67 indexed citations
12.
Reinert, Thomas, Michael Borre, Anders Christiansen, et al.. (2012). Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation. PLoS ONE. 7(10). e46297–e46297. 93 indexed citations
13.
Schepeler, Troels, Philippe Lamy, Jens R. Laurberg, et al.. (2012). A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response. Oncogene. 32(31). 3577–3586. 27 indexed citations
14.
Dyrskjøt, Lars, Karsten Zieger, Thomas Reinert, et al.. (2012). Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma. British Journal of Cancer. 107(1). 116–122. 69 indexed citations
15.
Dyrskjøt, Lars, Thomas Reinert, Alexey Novoradovsky, et al.. (2012). Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR. British Journal of Cancer. 107(8). 1392–1398. 27 indexed citations
16.
Reinert, Thomas, Charlotte Modin, Philippe Lamy, et al.. (2011). Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers. Clinical Cancer Research. 17(17). 5582–5592. 169 indexed citations
17.
Schepeler, Troels, Thomas Reinert, Marie S. Ostenfeld, et al.. (2008). Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer. Cancer Research. 68(15). 6416–6424. 419 indexed citations
18.
Paun, Andrea, Thomas Reinert, Zhaozhao Jiang, et al.. (2008). Functional Characterization of Murine Interferon Regulatory Factor 5 (IRF-5) and Its Role in the Innate Antiviral Response. Journal of Biological Chemistry. 283(21). 14295–14308. 105 indexed citations
19.
Soyka, Michael, Peggy Schmidt, Michael Franz, et al.. (2006). Treatment of alcohol withdrawal syndrome with a combination of tiapride/carbamazepine. European Archives of Psychiatry and Clinical Neuroscience. 256(7). 395–401. 17 indexed citations
20.
Reinert, Thomas, et al.. (1999). [Need for a substance abuse medicine qualified acute inpatient treatment program in alcohol dependence].. PubMed. 26(6). 294–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Butori Breakdown of academic impact, for papers by Gary L. Bratthauer Breakdown of academic impact, for papers by Ie Ming Shih Breakdown of academic impact, for papers by Chiara Casadio Breakdown of academic impact, for papers by Francesca Micci Breakdown of academic impact, for papers by Kung‐Chao Chang Breakdown of academic impact, for papers by Margaret Brandwein‐Gensler Breakdown of academic impact, for papers by Kolja Freier Breakdown of academic impact, for papers by Amit Roshan Breakdown of academic impact, for papers by H. Ewout Schaafsma
Rankless by CCL
2026